Latest Breaking News On - Amplyx pharmaceuticals inc - Page 1 : comparemela.com

Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Robertm brennerJoyce allaireMari purpuraMarshall fordyceWilliamd turnerAmplyx pharmaceuticals incPfizer incEuropean renal association congressExchange commissionVera therapeutics incRecent business highlightsChief medical officerChief developmentQuarter ended marchB cell activating factorInducing ligand

Vera Therapeutics : Provides Business Update and Reports First Quarter 2024 Financial Results - Form 8-K

Vera Therapeutics : Provides Business Update and Reports First Quarter 2024 Financial Results - Form 8-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Marshall fordyceWilliamd turnerMari purpuraJoyce allaireRobertm brennerAmplyx pharmaceuticals incPfizer incVera therapeutics incEuropean renal association congressExchange commissionVera therapeutics provides business updateReports first quarterRecent business highlightsChief medical officerChief development officerQuarter ended march

Basilea announces acquisition of fosmanogepix, a phase-3-ready broad-spectrum antifungal

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 13, 2023 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting.

Basel stadtSwitzerland generalUnited statesDavid veitchCresemba zevteraNils schrDrug administrationAmplyx pharmaceuticals incSwiss exchangeHead of corporate communications investor relationsAmerican thoracic societyBasilea pharmaceutica international ltdBasilea pharmaceutica ltdPfizer incPharmaceutica ltdAmplyx pharmaceuticals

Basilea announces acquisition of fosmanogepix, a

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 13, 2023 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a.

Basel stadtUnited statesSwitzerland generalNils schrCresemba zevteraDavid veitchDrug administrationSwiss exchangeAmplyx pharmaceuticals incAmerican thoracic societyHead of corporate communications investor relationsPfizer incBasilea pharmaceutica ltdBasilea pharmaceutica international ltdPharmaceutica ltdAmplyx pharmaceuticals

Vera Therapeutics Provides Business Update and Reports Third Quarter Financial Results

Vera Therapeutics Provides Business Update and Reports Third Quarter Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJoyce allaireMarshall fordycePfizer incAmerican society of nephrology kidney weekAmplyx pharmaceuticals incExchange commissionVera therapeutics incAmerican societyNephrology kidney weekKidney weekRecent business highlightsQuarter ended septemberB cell activating factorInducing ligandAmplyx pharmaceuticals